Abesamis, Lilia D.
HRN: 01-19-85 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/07/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/07/2023
01/14/2023
IV
600mg
Q8
Hospital Acquired Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes